biotech

  1. CryoVault Biotech India celebrates nine years of affordable healthcare solutions: bringing hope closer to home

    India PR DistributionBengaluru (Karnataka) [India], July 3: Bangalore-based CryoVault Biotech India, proudly commemorates nine years of affordable, transformative healthcare solutions . As an award-winning company, CryoVault Biotech India is dedicated to making biotech stem cell banking...
  2. Ajooni Biotech bags order worth Rs 4.95 crore from top Indian dairy supplier

    New Delhi, Pure vegetarian animal healthcare solutions provider Ajooni Biotech on Monday said it has received an order worth Rs 4.95 crore from a top Indian dairy supplier.Jasjot Singh, Managing Director, Ajooni Biotech, said in a statement, "We are thrilled to receive this order from such a...
  3. Biggest pineapple consignment of the year has raised hopes of farmers in Tripura

    Agartala (Tripura) [India], Pineapple farmers in Tripura have achieved a significant feat by producing a record breaking 30 metric tonnes (MT) of pineapples.This historic development, led by the Sheel Biotech team in collaboration with Tripura State Organic Farming Development Agency...
  4. Bharat Biotech adds ICMR as co-owner of Covid-19 vaccine patent

    Hyderabad (Telangana) [India], Bharat Biotech has added the Indian Council of Medical Research (ICMR) as co-owner of the COVID-19 vaccine patent.Notably, Bharat Biotech was working on developing the COVID-19 vaccine as a top priority to ensure availability of the product as soon as possible...
  5. Ajooni Biotech ties up with Avalon Bioenergy for sustainable Moringa processing

    New Delhi, Ajooni Biotech on Tuesday said it has collaborated with Avalon BioEnergy, the Indian subsidiary of US-based Avalon Energy Group, for sustainable processing of moringa in the country.The collaboration will set up processing plants, including crushing and drying mills, for processing...
  6. Ajooni Biotech Limited announced the acquisition of 555,000 sq.m. Yard land for Moringa plantation in Patan district of Gujarat

    PNNMumbai (Maharashtra) [India], June 15: Ajooni Biotech Ltd. (NSE: Ajooni), a pure vegetarian. Animal Health Care Solutions Company is pleased to announce the acquisition of 555,000 square yards (49,95,000 sq ft) of land near Harij village in Patan district, Gujarat. This strategic move is an...
  7. Q-Line Biotech Pvt. Ltd. and Boule Medical AB Collaboration: A Leap Forward in Healthcare Manufacturing in Lucknow

    Vision Communicatio Lucknow (Uttar Pradesh) [India], May 29: Under the framework of the Globa Investors Summit to be held in 2023, Q-Line Biotech Pvt. Ltd. Ltd. (POCT Group) has set up a state-of-the-art medical device manufacturing facility in Lucknow, Uttar Pradesh. And we are working for...
  8. Concord Biotech's public shareholders sold shares worth Rs 483 crore

    New Delhi: A public shareholder of pharmaceutical company Concord Biotech on Tuesday sold 3.4 per cent stake in the company for Rs 483 crore through an open market transaction.According to bulk deal data available with the National Stock Exchange (NSE), 1575773 Ontario Inc sold 35,48,211...
  9. Ajooni Biotech expects additional revenue of Rs 200 crore from commercial production of Moringa by FY 25-26

    New Delhi, Animal healthcare solutions provider Ajooni Biotech is expecting additional annual revenue of Rs 200 crore from commercial production of moringa by financial year 2025-26.The leading animal feed manufacturer on Monday revealed its plans for commercial production of Moringa by...
  10. Krishna Ella receives award from Johns Hopkins Bloomberg School of Public Health

    Dean Alan J. Dr. Ella received the award from McKenzie for her extraordinary leadership, enduring vision and contributions to improving public health.The Johns Hopkins Bloomberg School of Public Health recognizes Dr. Ella's pioneering work, remarkable impact and determination to develop an...
  11. Ajooni Biotech offers rights issue to raise Rs 44 crore

    New Delhi, Animal healthcare solutions firm Ajooni Biotech on Tuesday opened a rights issue with the aim of raising Rs 43.81 crore from existing shareholders.Ajooni Biotech will offer 8,76,13,721 fully paid equity shares of face value Rs 2 each at Rs 5 per equity share, aggregating to Rs 43.8...
  12. Rights worth Rs 43.81 crore of Ajooni Biotech Limited will open on May 21, 2024

    PN Ahmedabad (Gujarat) [India], May 20: Ajooni Biotech Lt. (NSE – Ajooni) – Leading and pure vegetarian. Anima Health Care Solutions Company is scheduled to open its rights issue of Rs 43.81 crore on May 21, 2024. The funds raised through the issue will be used to finance expenditure towards...
  13. Expert committee approves Bharat Biotech International's proposal to conduct phase-2 trials of TB vaccine: Sources

    New Delhi [India], The Subject Expert Committee (SEC), which comes under the Central Drugs Standard Control Organization (CDSCO), has approved the Phase II clinical trials of vaccine major Bharat Biotech International's Mycobacterium Tuberculosis (Live Attenuated) vaccine. The proposal to...
  14. Ajooni Biotech receives upgraded credit rating and rights issue details

    PN Punjab [India], May 3: Ajooni Biotech Limited is thrilled to announce that CRISIL Limited has upgraded the company's long-term credit facilities rating to "CRISIL BB+ Stable". This upgrade underlines the company's ongoing efforts to improve its risk profile, revenue flows and operating...
  15. Covaxin developed focusing on safety first: Bharat Biotech

    New Delhi, Amid AstraZeneca's entry, Bharat Biotech on Thursday claimed that its Covid-19 vaccine Covaxy is safe and devoid of any side effects as Covishield can cause complications in rare cases.In a statement, the company said Covaxin was developed focusing on safety first, followed by...
  16. CSIR-NIIST opens innovation center for startups

    Thiruvananthapuram, To boost the startup ecosystem, CSIR-Neshna Institute for Interdisciplinary Science Technology (CSIR-NIIST) has set up a dedicated innovation center at its campus here to bring forward technology-driven start-ups with innovative and marketable products. Have installed. ...
  17. Bharat Biotech says Covaxin has excellent safety record

    The Hyderabad-based company issued a statement amid questions being raised in some quarters over the safety of Covid vaccines after global drugmaker AstraZeneca admitted that its Covid vaccine Covishield, developed by researchers at the University of Oxford, may cause a blood clotting disorder...
  18. "Safety is the primary focus for all our vaccines": Covaxin-developer Bharat Biotech amid reports on AstraZeneca vaccine

    New Delhi [India], Amid reports of possible rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which has developed Covaxin, said in a statement that the vaccine will be developed "with a focus on safety first." "Together" will be developed. It said Covaxin was the...
  19. Bharat Biotech promoter Krishna Ella is the new president of the Indian Vaccine Manufacturers Association.

    Hyderabad, Indian Vaccine Manufacturers Association (IVMA) has announced Bharat Biotech co-founder, Executive Chairman Krishna M Ella as the new President of the association for a period of two years from April 2024.A press release from Bharat Biotech said Ella takes over as president from...
  20. "Recapitulating India's progress": Bharat Biotech co-founder on VP Dhankhar's pharma major journey

    Malkajgiri (Telangana) [India], Expressing happiness over Vice President Jagadi Dhankhar's visit to Bharat Biotech on Friday, Suchitra Ella, Managing Director and Co-Founder of the pharma major, said it came as a "repetition of work and visit". is marked. Since the inception of the company in...